These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 10634808

  • 1. Effect of macrophage-derived mouse ApoE, human ApoE3-Leiden, and human ApoE2 (Arg158-->Cys) on cholesterol levels and atherosclerosis in ApoE-deficient mice.
    Van Eck M, Herijgers N, Van Dijk KW, Havekes LM, Hofker MH, Groot PH, Van Berkel TJ.
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):119-27. PubMed ID: 10634808
    [Abstract] [Full Text] [Related]

  • 2. Reversal of hypercholesterolemia in apolipoprotein E2 and apolipoprotein E3-Leiden transgenic mice by adenovirus-mediated gene transfer of the VLDL receptor.
    van Dijk KW, van Vlijmen BJ, van der Zee A, van't Hof B, van der Boom H, Kobayashi K, Chan L, Havekes LM, Hofker MH.
    Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):7-12. PubMed ID: 9445249
    [Abstract] [Full Text] [Related]

  • 3. Hyperlipidemia of ApoE2(Arg(158)-Cys) and ApoE3-Leiden transgenic mice is modulated predominantly by LDL receptor expression.
    van Dijk KW, van Vlijmen BJ, de Winther MP, van 't Hof B, van der Zee A, van der Boom H, Havekes LM, Hofker MH.
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2945-51. PubMed ID: 10591674
    [Abstract] [Full Text] [Related]

  • 4. Chylomicron remnant uptake in the livers of mice expressing human apolipoproteins E3, E2 (Arg158-->Cys), and E3-Leiden.
    Lee SJ, Grosskopf I, Choi SY, Cooper AD.
    J Lipid Res; 2004 Dec; 45(12):2199-210. PubMed ID: 15466367
    [Abstract] [Full Text] [Related]

  • 5. Isoform-specific effects of apolipoprotein E on atherogenesis: gene transduction studies in mice.
    Yoshida H, Hasty AH, Major AS, Ishiguro H, Su YR, Gleaves LA, Babaev VR, Linton MF, Fazio S.
    Circulation; 2001 Dec 04; 104(23):2820-5. PubMed ID: 11733401
    [Abstract] [Full Text] [Related]

  • 6. Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice.
    Tsukamoto K, Tangirala R, Chun SH, Puré E, Rader DJ.
    Arterioscler Thromb Vasc Biol; 1999 Sep 04; 19(9):2162-70. PubMed ID: 10479659
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impaired secretion of apolipoprotein E2 from macrophages.
    Fan D, Qiu S, Overton CD, Yancey PG, Swift LL, Jerome WG, Linton MF, Fazio S.
    J Biol Chem; 2007 May 04; 282(18):13746-53. PubMed ID: 17341585
    [Abstract] [Full Text] [Related]

  • 9. Accelerated atherosclerosis in C57Bl/6 mice transplanted with ApoE-deficient bone marrow.
    Van Eck M, Herijgers N, Vidgeon-Hart M, Pearce NJ, Hoogerbrugge PM, Groot PH, Van Berkel TJ.
    Atherosclerosis; 2000 May 04; 150(1):71-80. PubMed ID: 10781637
    [Abstract] [Full Text] [Related]

  • 10. Bone marrow transplantation in apolipoprotein E-deficient mice. Effect of ApoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis.
    Van Eck M, Herijgers N, Yates J, Pearce NJ, Hoogerbrugge PM, Groot PH, Van Berkel TJ.
    Arterioscler Thromb Vasc Biol; 1997 Nov 04; 17(11):3117-26. PubMed ID: 9409301
    [Abstract] [Full Text] [Related]

  • 11. Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice.
    Tsukamoto K, Smith P, Glick JM, Rader DJ.
    J Clin Invest; 1997 Jul 01; 100(1):107-14. PubMed ID: 9202062
    [Abstract] [Full Text] [Related]

  • 12. Essential role for the (hepatic) LDL receptor in macrophage apolipoprotein E-induced reduction in serum cholesterol levels and atherosclerosis.
    Van Eck M, Van Dijk KW, Herijgers N, Hofker MH, Groot PH, Van Berkel TJ.
    Atherosclerosis; 2001 Jan 01; 154(1):103-12. PubMed ID: 11137088
    [Abstract] [Full Text] [Related]

  • 13. Genetic deletion of tissue-type plasminogen activator (t-PA) in APOE3-Leiden mice reduces progression of cholesterol-induced atherosclerosis.
    Rezaee F, Gijbels M, Offerman E, Verheijen J.
    Thromb Haemost; 2003 Oct 01; 90(4):710-6. PubMed ID: 14515193
    [Abstract] [Full Text] [Related]

  • 14. Isoform-dependent cholesterol efflux from macrophages by apolipoprotein E is modulated by cell surface proteoglycans.
    Hara M, Matsushima T, Satoh H, Iso-o N, Noto H, Togo M, Kimura S, Hashimoto Y, Tsukamoto K.
    Arterioscler Thromb Vasc Biol; 2003 Feb 01; 23(2):269-74. PubMed ID: 12588770
    [Abstract] [Full Text] [Related]

  • 15. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.
    Nakamura T, Kawarabayashi T, Ueda T, Shimomura S, Hoshino M, Itoh K, Ihara K, Nakaji S, Takatama M, Ikeda Y, Shoji M.
    J Alzheimers Dis; 2023 Feb 01; 93(1):333-348. PubMed ID: 36970894
    [Abstract] [Full Text] [Related]

  • 16. Intramuscular injection of a plasmid vector expressing human apolipoprotein E limits progression of xanthoma and aortic atheroma in apoE-deficient mice.
    Athanasopoulos T, Owen JS, Hassall D, Dunckley MG, Drew J, Goodman J, Tagalakis AD, Riddell DR, Dickson G.
    Hum Mol Genet; 2000 Oct 12; 9(17):2545-51. PubMed ID: 11030760
    [Abstract] [Full Text] [Related]

  • 17. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.
    Zhang W, Yancey PG, Su YR, Babaev VR, Zhang Y, Fazio S, Linton MF.
    Circulation; 2003 Nov 04; 108(18):2258-63. PubMed ID: 14581413
    [Abstract] [Full Text] [Related]

  • 18. Elimination of macrophage-specific apolipoprotein E reduces diet-induced atherosclerosis in C57BL/6J male mice.
    Boisvert WA, Curtiss LK.
    J Lipid Res; 1999 May 04; 40(5):806-13. PubMed ID: 10224149
    [Abstract] [Full Text] [Related]

  • 19. Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: an immunohistochemical study.
    Gijbels MJ, van der Cammen M, van der Laan LJ, Emeis JJ, Havekes LM, Hofker MH, Kraal G.
    Atherosclerosis; 1999 Mar 04; 143(1):15-25. PubMed ID: 10208477
    [Abstract] [Full Text] [Related]

  • 20. Hyperlipidemia in APOE2 transgenic mice is ameliorated by a truncated apoE variant lacking the C-terminal domain.
    Gerritsen G, Kypreos KE, van der Zee A, Teusink B, Zannis VI, Havekes LM, van Dijk KW.
    J Lipid Res; 2003 Feb 04; 44(2):408-14. PubMed ID: 12576523
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.